These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 6460229)

  • 1. Central action of narcotic analgesics. IX. Participation of serotonin in the development of tolerance to cataleptogenic effects of morphine in rats.
    Langwiński R; Fidecka S
    Pol J Pharmacol Pharm; 1981 Nov; 33(4):437-44. PubMed ID: 6460229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central action of narcotic analgesics. VII. The role of serotonin in the development of morphine tolerance in the locomotor activity test in mice and rats.
    Langwiński R; Fidecka S
    Pol J Pharmacol Pharm; 1981; 33(2):193-202. PubMed ID: 6458804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central action of narcotic analgesics. V. Participation of serotonin in the mechanism of action of narcotic analgesics.
    Fidecka S; Langwiński R
    Pol J Pharmacol Pharm; 1979; 31(5):461-71. PubMed ID: 44745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central action of narcotic analgesics. VI. Further studies on the participation of serotonin in the action of analgesics.
    Malec D
    Pol J Pharmacol Pharm; 1980; 32(5):665-72. PubMed ID: 6115369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of amphetamine and nomifensine on the development of morphine tolerance in the test of hypermotility in mice and catalepsy in rats.
    Fidecka S; Langwiński R
    Pol J Pharmacol Pharm; 1983; 35(6):503-10. PubMed ID: 6687158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Participation of serotonin in development of morphine dependence in mice and rats.
    Kruszewska A
    Pol J Pharmacol Pharm; 1980; 32(5):655-63. PubMed ID: 6973754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental data for interaction of morphine and serotoninergic substances and their action upon some CNS-functions.
    Ovtcharov R
    Acta Physiol Pharmacol Bulg; 1982; 8(1-2):64-70. PubMed ID: 6214924
    [No Abstract]   [Full Text] [Related]  

  • 8. Central action of narcotic analgesics. I. Catalepsy and stereotypy in rats and narcotic analgesics.
    Malec D; Fidecka S; Langwiński R
    Pol J Pharmacol Pharm; 1977; 29(3):177-93. PubMed ID: 560683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central action of narcotic analgesics. VIII. The effect of dopaminergic stimulants on the action of analgesics in rats.
    Malec D; Langwiński R
    Pol J Pharmacol Pharm; 1981 Oct; 33(3):273-82. PubMed ID: 6119681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of serotonin-active drugs on prolactin secretion in male rats.
    Jagiełło-Wójtowicz E; Załuska W; Szponar J; Surmaczyńska B; Wójcicki M; Kleinrok Z
    Pol J Pharmacol Pharm; 1988; 40(1):73-80. PubMed ID: 2467272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of serotonergic agents on the body temperature.
    Pawlowski L
    Pol J Pharmacol Pharm; 1976; 28(6):615-23. PubMed ID: 138132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure activity relationship studies with hypothalamic peptide hormones. I. Effect of melanotropin release inhibiting factor and analogs on tolerance to morphine in the rat.
    Bhargava HN; Kim HS
    J Pharmacol Exp Ther; 1982 Feb; 220(2):394-8. PubMed ID: 6120229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of H2 receptor blockade upon hypothermic, cataleptogenic and antinociceptive action of prostacyclin (PGI)2 administered into the lateral rat brain ventricle.
    Brus R; Krzemiński T; Juraszczyk Z; Kurocok A
    Biomed Biochim Acta; 1985; 44(4):637-44. PubMed ID: 2862862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of L-5-hydroxytryptophan and DL-p-chlorophenylalanine on neurophysiological profiles of serotonin reuptake inhibitors in rabbits.
    Bo P; Patrucco M; Maurelli M; Camana C; Savoldi F
    Farmaco Sci; 1987 Aug; 42(8):595-601. PubMed ID: 2959563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation by serotonin of glutamate-induced lethality in mice.
    Kamei J; Igarashi H; Kasuya Y
    Res Commun Chem Pathol Pharmacol; 1991 Nov; 74(2):167-84. PubMed ID: 1839809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphine analgesia and its modification by drugs altering serotonin (5-HT) and dopamine levels in the brain.
    Shinde S; Gupta SK
    Indian J Physiol Pharmacol; 1977; 21(1):72-4. PubMed ID: 301504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decrease of tolerance development to morphine by 5-hydroxytryptophan and some related drugs.
    Contreras E; Tamayo L; Quijada L; Silva E
    Eur J Pharmacol; 1973 Jun; 22(3):339-43. PubMed ID: 4270007
    [No Abstract]   [Full Text] [Related]  

  • 18. The influence of gabaergic system on cataleptogenic action of analgesics and haloperidol.
    Malec D; Langwiński R
    Pol J Pharmacol Pharm; 1986; 38(5-6):501-7. PubMed ID: 3575168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible involvement of serotonergic neurotransmission in neurotensin but not morphine analgesia.
    Long JB; Kalivas PW; Youngblood WW; Prange AJ; Kizer JS
    Brain Res; 1984 Sep; 310(1):35-41. PubMed ID: 6089968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attenuation of tolerance to opioid-induced antinociception and protection against morphine-induced decrease of neurofilament proteins by idazoxan and other I2-imidazoline ligands.
    Boronat MA; Olmos G; García-Sevilla JA
    Br J Pharmacol; 1998 Sep; 125(1):175-85. PubMed ID: 9776358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.